BIONIC SKINS LLC

Medtech · Private

computationally derived transtibial prosthetic sockets and liners, designed via biophysical modeling and finite element analysis to minimize contact pressure

Grants
$2.0M
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
$2.4M
2 awards · Defense
#199 of 4531 in medtech
Patents
3
2 granted · 1 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal contractDepartment of Defense · Award Of Bionic Skins' Dha SBIR 19.1 Phase I Medical R&d Contract From Proposal H191-009-0001 "quantitative Production Of A Transtibial Prosthetic Interface: From Digital Design To Digital Manufacturing"$162,496
Federal contractDepartment of Defense · Award Of Bionic Skins' Dha SBIR Phase II Medical R&d Contract For "quantitative Production Of A Transtibial Prosthetic Interface: From Digital Design To Digital Manufacturing"$2,199,798
Federal grantDepartment of Health and Human Services · Phase II · Improving the health status of dysvascular amputees by deploying digital prosthetic interface technology in combination with exercise intervention$1,052,841
Federal grantDepartment of Health and Human Services · Phase II · Improving the health status of dysvascular amputees by deploying digital prosthetic interface technology in combination with exercise intervention$906,898
Federal grant · SBIR/STTRFederal contract · USAspending

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
196EMITECH, INC.$2.4M—
197Color Health$2.4M$263M
198DOSEOPTICS LLC$2.4M—
199BIONIC SKINS LLC$2.4M—
200FERRO SOLUTIONS, INC.$2.3M—
201Simbex LLC$2.3M—
202ORTHOPEDIATRICS CORP$2.3M$39M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 2 granted of 3

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.